Objectives. To study the survival rate and prognostic indicators of systemic lupus erythematosus (SLE) in a southern Chinese population.
Systemic lupus erythematosus (SLE ) is a multisystem 10-yr survival for patients seen between 1976 and 1986 than that between 1964 and 1975 (76% vs 64%, autoimmune disease that predominantly affects women P = 0.03). The improvement of SLE survival can be of childbearing age. It is also a major cause of mortality attributed to a number of factors such as the early and morbidity in the young population [1] . The prognodiagnosis of renal disease, better serological monitoring, sis of SLE in the Western world has improved remarkmore judicious use of corticosteroids and cytotoxic ably in the past few decades, from a 5-yr survival rate agents, availability and advancement of renal replaceof only 50% in the 1950s [2] to a 10-yr survival rate of ment therapies, and better management of associated nearly 90% in the 1990s [3, 4] . However, poor survival complications like infection, hyperlipidaemia and of SLE is still reported in certain ethnic groups such as hypertension. Indians [5] , Black Caribbeans [6 ] and Hispanics [7] . A Despite the overall improvement in the survival of recent study from Donadio et al. [8] reported a lower patients with SLE, 10-25% of patients still succumb survival rate in patients with lupus nephritis seen at the within 10 yr of disease onset [9] . Severe organ involveMayo Clinic between 1964 and 1986. The 5-, 10-and ment related to SLE itself [10-13] and infection [4, 6, 20 -yr survival rates were 80, 69, and 53%, respectively. 10, [14] [15] [16] remain the main causes of early mortality. The authors reported a significant improvement in the It has been reported that Asian SLE patients living in the USA and UK have more serious organ manifesta-related to the poorer socio-economic status of the AsianClinics/ACR (SLICC/ACR) index [24] . Damage was defined as irreversible impairment that was present after Americans remains to be confirmed. However, data regarding survival of SLE in southern Chinese are the diagnosis of SLE and persistent for more than 6 months, irrespective of whether it was related to limited. In a study from Singapore, the causes of 67 deaths of SLE patients over a 4-yr period were described disease activity or treatment. For patients whose SLE was diagnosed before 1997, damage scores were obtained [20] . The actuarial survival rate of their patients was not mentioned and the study population consisted of retrospectively. After 1997, the damage index was scored yearly. The total cumulative damage scores were mixed ethnicity. In an earlier study from our group, the 5-and 10-yr survival rates of 183 patients with biopsysummated for each patient at the end of the study. For patients who died during the follow-up period, the proven lupus nephritis seen between 1976 and 1997 were reported to be 98.9% and 94.4%, respectively [21] .
cumulative damage scores just before their death were taken for analysis. However, this study did not include patients with renal disease but without histological documentation and Laboratory evaluation those with milder disease with predominant musculoskeletal and dermatological manifestations. Moreover, as Antinuclear antibodies (ANA) were determined by indirect immunofluorescence. Anti-dsDNA was assayed the study was conducted retrospectively, selection bias and incompleteness of records were inevitable. In the using a standard enzyme-linked immunosorbent assay ( ELISA) procedure calibrated with an international current study, we prospectively followed a cohort of SLE patients newly diagnosed between 1992 and 1999 standard serum ( Wo/80). The cut-off point for positivity was set at 154 IU/ml. could not be assumed, the Mann-Whitney U-test was autoantibody profile. Patients were followed-up proused instead. Correlation study between various continuspectively at regular intervals of 6-8 weeks. More freous data was performed by Spearman's rank correlation quent follow-up was arranged for patients who had test. Univariate and multivariate analysis of the predictsevere organ involvement, who had just had a disease ive factors for damage were achieved by the chi-square flare or who were receiving intensive immunosupprestest and logistic regression, respectively and the odds sion. Damage scores in each system and mortality data ratios/relative risks were calculated. Estimates of the were recorded during the disease course of our patients.
survival of our patients were studied by life table analysis Disease activity was measured by the SLE Disease using the Kaplan-Meier method. Survival curves with Activity Index (SLEDAI ) [23] . SLEDAI scores were the presence and absence of particular features were obtained at the time of first presentation and subsecompared using the non-parametric log rank test (univaquent visits. Assessment of organ damage was made riate model ). Multivariate analysis of the risk factors for survival was performed using the Cox proportional using the Systemic Lupus International Collaborating T 1. Clinical features of our cohort of SLE patients at disease presentation and the prevalence of various organ manifestations (n = 182) aP-values were corrected by the Bonferroni method and were considered significant when they were <0.05; NS = non-significant. bCNS manifestations included the following: seizure, psychosis, aseptic meningitis, cognitive dysfunction and transverse myelitis. cRenal disease was defined as proteinuria >0.5 g/day or biopsy-proven nephritis. nephritis was as follows: class IV (33, 65%), class III (10, 20%), class II (1, 2%) and class V (7, 14%). At the time of diagnosis of SLE, 55 and 52% of patients, gender difference in the prevalence of major organ manifestations (data not shown). respectively, had positive anti-dsDNA and low serum C3 levels. These percentages increased significantly
At presentation Prevalence of various clinical features
The mean duration of follow-up of our patients was 45.2 ± 1.7 months (range 6-87). Thirty-one per cent of during follow-up (69 and 71% for anti-dsDNA and C3, respectively, P = 0.01 in both). Table 2 shows the prevalour patients had organ damage at the time of data analysis. Twenty-three per cent had a SLICC score of ence of various anti-ENA and antiphospholipid antibodies in our cohort. Among the anti-ENA antibodies, antione and only 8% of patients had a SLICC score of two or more. Table 3 shows the number of patients with Ro was the commonest (65%). There was no significant damage in various systems. The kidneys were the comwas mainly indicated for renal, CNS and haematological disease. The cumulative percentages of patients monest organ being damaged, followed by the CNS, gonads and skin. The median SLICC score of the whole who received hydroxychloroquine, azathioprine and cyclophosphamide were 59, 58 and 26%, respectively. cohort was 0 (range 0-3, interquartile range = 1) and for those who had damage, the median SLICC score During follow-up, nine of our patients died-three of disease-related complications (pulmonary haemorrhage was 1 (range 1-3, interquartile range = 1). No significant difference in damage scores could be demonstrated in two and uncontrolled severe pulmonary hypertension in one) and six of infections (nocardial meningitis in between female and male patients (Mann-Whitney U-test, P = 0.29). Age at disease onset and disease one, disseminated cytomegalovirus infection in one, disseminated tuberculosis in one, bronchopneumonia duration did not correlate with SLICC scores (rho = 0.06, P = 0.42 and rho = 0.10, P = 0.20, respectively).
with or without septicaemia in the remaining three). Six other patients developed end-stage renal failure and Univariate and multivariate analysis was performed to study the predictive factors for damage and the results were dialysed, but none was transplanted. All of these dialysed patients survived. Figure 1 shows the survival are shown in Table 4 . Discoid lesions, CNS disease, renal disease and treatment with high-dose steroid and renal survival (survival without dialysis) curves for our cohort of patients. The 3-, 5-and 7-yr survival and (Á1 mg/kg/day prednisone or equivalent, or pulse methylprednisolone therapy) or cytotoxic agents (cyclorenal survival rates were 97, 93, 93%, and 97, 90, 84%, respectively. phosphamide or azathioprine) were univariately associated with damage. Logistic regression with outcome Risk factors for survival were studied by both univariate ( log rank test) and multivariate analysis (Cox regresbeing damage and the prevalence of other clinical features, autoantibodies, demographic data (e.g. age and sion), using the prevalence of various clinical features, demographic data such as age and sex, autoantibodies sex) and drug treatment being predictor variables showed that discoid lesions, CNS disease and treatment and presence of damage as predictor variables. Highdose steroid treatment was found to be a univariate with high-dose steroid were independent predictors for damage.
As renal damage was the commonest organ damage in our patients, a separate logistic regression analysis was performed with outcome being renal damage and other clinical variables described above being predictors. It was found that younger age at disease onset (P = 0.02) and thrombocytopenia [relative risk 41.6 (95% confidence interval 2.3-759), P = 0.01] were independent risk factors for renal damage.
Regarding immunosuppressive treatment for our cohort of patients, 163 (90%) were treated with corticosteroids, 84 (52%) of whom initially received a highdose regimen (oral prednisone Á1 mg/kg/day or F. 1. Cumulative probability of survival in our cohort of SLE patients (n = 182). intravenous pulse methylprednisolone therapy) which 
Discussion
This was a prospective study of the survival and prognostic indicators of SLE in a southern Chinese population. The slight increase in male predominance in our cohort could be the result of the referral pattern in our unit. With the recent increase in the awareness of SLE in males, quite a number of patients with discoid/ subacute cutaneous lupus lesions or haemolytic anaemia/thrombocytopenia with positive immune markers were referred to us by dermatologists and haematologists. The prevalence of anti-Ro in our SLE patients is similar to two other southern Chinese series reported previously [25, 26 ] and appears to be higher than that reported in Caucasians. As the methodology of anti-Ro detection is similar (immunodiffusion), the difference in the prevalence in this antibody is likely to be a genuine inter-ethnic difference in disease characteristics. The overall 5-yr survival rate of our SLE patients was 93%. Because of the problem of recording filing, data regarding the survival of our SLE patients in the 1980s are unavailable for comparison. The survival of our SLE cohort is similar to that of the Caucasian series reported in the 1990s [3, 4, 27] . SLE mortality tends to vary among different geographical areas and ethnic groups. Direct comparison of the survival rates among different studies is not easy because of the discrepancies in patient selection and treatment protocols. Most published survival studies of SLE have been retrospective and selection bias and incompleteness of medical records are major flaws. Moreover, the proportion of patients with severe organ manifestations included in different series as a result of referral pattern may also influence the survival rates. Prospective studies are therefore necessary. follows a bimodal pattern [12] . Early mortality of SLE is often due to complications related to the active SLE predictor for survival (P = 0.047), while high-dose sterprocess itself and infection, while vascular events and oid treatment and thrombocytopenia were independent end organ failure unrelated to active SLE contribute to risk factors predicting mortality in the multivariate late mortality [16 ] . The main causes of death in our model ( Table 5) . Figure 2a -c shows the survival curves patient cohort were infection and active SLE with severe of our patients according to the presence and absence organ involvement, which are consistent with those of thrombocytopenia, treatment with high-dose steroid reported in other series. Because of the relatively short and presence or absence of damage. The presence of duration of follow-up, long-term survival and causes of damage did not predict for mortality in both univariate late mortality in our cohort have yet to be determined by a longer period of observation. and multivariate analyses.
A number of lupus-and non-lupus-related factors act, glaucoma, secondary diabetes, osteoporosis and its complications, which contribute significantly to damage have been described in association with the prognosis of SLE [28] . Major organ manifestations, particularly and mortality in our cohort. Our result is in keeping with that from Massado et al. [33] who also demon-CNS and renal disease, have long been identified as markers of poor prognosis [29] . Patients who die of strated that high-dose steroid for the treatment of patients with more severe disease was associated with active SLE are more likely to have CNS disease [12] . Organic brain syndrome was reported to be a poor higher mortality in their Chilean SLE patients. Given the strong relationship between heavy immunosuppresprognostic indicator for survival in an early study by Esters and Christian [29] . Moreover, seizure was found sion and organ damage, efforts should assiduously be made to avoid unnecessary over-immunosuppressive to be associated with a poorer overall survival of SLE in a recent study by Ward et al. [9] . Lupus nephritis, treatment in patients with SLE. Race appears to play a role in disease prognosis in especially diffuse proliferative glomerulonephritis, carries a poor prognosis in most studies [4, 8, 9, 27, [30] [31] [32] [33] .
SLE, although it is difficult to separate the effect of race from socio-economic status. Non-White populations Elevated creatinine, reduced creatinine clearance and progressive WHO class of lupus nephritis were associresiding in Hawaii, which were exclusively Asians, were found to have more serious SLE and mortality than ated with decreased survival. We, however, could not demonstrate either CNS or renal disease to be a signifiWhites [18] . This may possibly be related to the lower socio-economic condition of the Asian-Americans. cant predictor for survival in our cohort. In fact, all our six patients who developed end-stage renal failure surBlack patients, when compared with Whites, also have more severe organ manifestations and poorer survival vived with dialysis. Those who died during the study period did not have uraemia. This may reflect that with [1, 6, 34] . However, a multicentre study of a large cohort of SLE patients demonstrated that apparent the availability and improvement in renal replacement therapies, renal disease is no longer a major determinant racial differences in survival could be accounted for by differences in medical insurance status between Blacks of survival of SLE. The contribution of CNS disease to survival in our patients is difficult to evaluate because and Whites [32] . Moreover, Ward et al.
[35] also showed that socio-economic status, instead of race, is a strong of the relatively small number of patients with CNS manifestations.
indicator for survival. The age at onset of SLE has also been reported as a Haematological manifestations, in particular thrombocytopenia, have also been cited as adverse factors for significant predictor for survival, although currently available data are conflicting. In the multicentre study poor outcome in SLE [4, 15, 27, 33] . This is in keeping with our findings that thrombocytopenia is a risk factor by Ginzler et al. [32] , better 1-and 5-yr survival rates were demonstrated in older SLE patients. Moreover, for mortality in the multivariate model. However, we did not differentiate between the effect of different paediatric-onset SLE patients have been associated with a worse prognosis [36 ] . However, a study comparing degrees of thrombocytopenia in our statistical analysis. Apart from those patients who died of pulmonary the outcome of adult-and childhood-onset SLE patients did not reveal any difference in the 5-yr survival rates haemorrhage, which was thought to be caused by fulminant vasculitis, no other patients suffered from sig- [37] . On the contrary, three recent studies showed that increasing age is a risk factor for death [15, 27, 35] . nificant morbidity and mortality secondary to bleeding complications. The contribution of thrombocytopenia This is in contradiction to the common observation that late-onset SLE often runs a more benign disease course to a poorer survival in our patients could possibly result from its statistical association with nephritis (P = 0.03, [38, 39] and to our data that older age at disease onset predicts for less renal damage. The effect of gender on chi-square test) and haemolytic anaemia (P < 0.001, chisquare test), which in turn were the main indications SLE survival is also controversial. Male SLE patients were reported to have more severe renal disease and for heavy immunosuppressive therapy at the time of diagnosis of SLE.
reduced survival [4, 40, 41] when compared with their female counterparts. However, other studies failed to Treatment is a pivoting factor affecting survival of SLE. Judicious use of steroid and cytotoxic agents such show a gender difference in damage and mortality rates of SLE [27, 42, 43] . We were unable to demonstrate a as cyclophosphamide and azathioprine to achieve a better control of disease activity is one of the wellcontribution of either age at onset or sex to survival in our patients. No gender differences in major organ recognized reasons for the improvement in survival of SLE in recent years. However, heavy immunosuppresmanifestations, damage scores and survival rates could be demonstrated either. sion, such as megadoses of steroid, may adversely affect short-term survival of SLE because of the risk of infecThere is still little information in the literature regarding the relationship between damage and survival in tion. In the current study we have shown that initial treatment with high-dose oral prednisone or intravenous SLE patients. In a retrospective study by Stoll et al.
[44] that involved an inception cohort of 80 SLE methylprednisolone bolus is a significant risk factor for damage and mortality in both the univariate and multivpatients, it was reported that the mean renal and pulmonary scores at 1 yr after the diagnosis of SLE preariate models. High-dose steroid treatment is associated with a number of side-effects such as susceptibility to dicted for renal failure and mortality, respectively, within 10 yr. Because of the problem of obtaining reliable opportunistic infection, avascular bone necrosis, catar-
